Search

everythinglearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Suppressing certain hormones might help prevent prostate cancer.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

COVID-19 may harm male fertility and damage the reproductive system.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Long-term use of dutasteride can cause permanent erectile dysfunction in rats.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Antiandrogen therapy helps treat genetic hair loss.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

No definitive link between finasteride and male breast cancer, but further research is needed.

Some skin diseases and their treatments can negatively affect male fertility.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The article concludes that a balance is needed between individual healthcare needs and societal resources when it comes to lifestyle drugs, with a call for compassionate policy application.

California Ground Squirrel hair can indicate environmental health by showing element accumulation.

Finasteride causes sperm production decrease in Mesocricetus auratus.